Reply to Fredrik Liedberg, Johan Abrahamsson, and Johannes Bobjer's Letter to the Editor re: Keisuke Shigeta, Kazuhiro Matsumoto, Koichiro Ogihara, et al. Does Neoadjuvant Chemotherapy have Therapeutic Benefit for Node-positive Upper Tract Urothelial Carcinoma? Results of a Multi-center Cohort Study. Urol Oncol. In press. https://doi.org/10.1016/j.urolonc.2021.07.029: A Plea for Uniform Terminology for Patients with Urothelial Carcinoma Treated with Chemotherapy Before Consolidative Surgery with Curative Intent: Induction Versus Neoadjuvant Chemotherapy: Need for Debate on the Optimized Treatment Strategy for Node-positive Upper Tract Urothelial Carcinoma

Eur Urol. 2022 Jan;81(1):e20-e21. doi: 10.1016/j.eururo.2021.10.008. Epub 2021 Oct 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Carcinoma, Transitional Cell* / drug therapy
  • Cohort Studies
  • Female
  • Humans
  • Male
  • Neoadjuvant Therapy
  • Urinary Bladder Neoplasms* / pathology